Maia Biotechnology Stock Investor Sentiment

MAIA Stock  USD 2.01  0.27  15.52%   
About 53% of MAIA Biotechnology's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding MAIA Biotechnology suggests that some traders are interested. The current market sentiment, together with MAIA Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use MAIA Biotechnology stock news signals to limit their universe of possible portfolio assets.
  

MAIA Biotechnology Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards MAIA Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at finance.yahoo.com         
MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Ce...
Yahoo News
2 days ago at gurufocus.com         
Insider Buying Ramiro Guerrero Acquires 73,333 Shares of MAIA Biotechnology Inc
Gurufocus Stories at Macroaxis
3 days ago at finance.yahoo.com         
MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately 1.43 Million
Yahoo News
3 days ago at seekingalpha.com         
Acquisition by Smith Stan of 50000 shares of MAIA Biotechnology at 1.87 subject to Rule 16b-3
seekingalpha News
six days ago at aol.com         
October 7thmade me realize being trans is a luxury belief so Im detransitioning
news
over a week ago at news.google.com         
MAIA Biotechnology, Inc. announced that it expects to receive 2.715 million in funding -February 17,...
Google News at Macroaxis
over a week ago at finance.yahoo.com         
MAIA Biotechnology Announces Private Placement of 2,715,000
Yahoo News
over two weeks ago at www.macroaxis.com         
Acquisition by Jeffrey Himmelreich of 10000 shares of MAIA Biotechnology at 1.81 subject to Rule 16b...
Macroaxis News
over two weeks ago at news.google.com         
MAIA Biotechnology Updates Executive Compensation Packages - TipRanks
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
MOGUL.sg launches MAIA - Singapores first virtual property agent, built using Google Cloud AI, that ...
Yahoo News
over three weeks ago at finance.yahoo.com         
MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Sm...
Yahoo News
over a month ago at finance.yahoo.com         
MAIA Biotechnology to Present at Biotech Showcase 2025
Yahoo News
over a month ago at news.google.com         
MAIA Biotechnology enters clinical supply agreement with BeiGene for THIO - TipRanks
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Theagene Jean-manasse of 10225 shares of MAIA Biotechnology at 1.98 subject to Rule 1...
Macroaxis News
over two months ago at finance.yahoo.com         
MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings
Yahoo News
Far too much social signal, news, headlines, and media speculation about MAIA Biotechnology that are available to investors today. That information is available publicly through MAIA media outlets and privately through word of mouth or via MAIA internal channels. However, regardless of the origin, that massive amount of MAIA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MAIA Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MAIA Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MAIA Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MAIA Biotechnology alpha.

MAIA Biotechnology Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Chaouki Steven M of 34641 shares of MAIA Biotechnology at 1.17 subject to Rule 16b-3
11/27/2024
2
MAIA Biotechnology announces 950,000 private placement
12/10/2024
3
Acquisition by Guerrero Ramiro of 53418 shares of MAIA Biotechnology at 2.08 subject to Rule 16b-3
12/13/2024
4
MAIA soars after its cancer drug receives FDA rare pediatric disease designation - Kursiv Media
12/17/2024
5
Acquisition by Theagene Jean-manasse of 10225 shares of MAIA Biotechnology at 1.98 subject to Rule 16b-3
12/31/2024
6
MAIA Biotechnology enters clinical supply agreement with BeiGene for THIO - TipRanks
01/07/2025
7
MOGUL.sg launches MAIA - Singapores first virtual property agent, built using Google Cloud AI, that puts the power of AI into the homebuyers hands for free
02/05/2025
8
Acquisition by Jeffrey Himmelreich of 10000 shares of MAIA Biotechnology at 1.81 subject to Rule 16b-3
02/10/2025
9
MAIA Biotechnology Announces Private Placement of 2,715,000
02/18/2025
10
Acquisition by Smith Stan of 50000 shares of MAIA Biotechnology at 1.87 subject to Rule 16b-3
02/24/2025

Complementary Tools for MAIA Stock analysis

When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities